With combined data from the US Linked Birth Cohort Data, Natality Data and Fetal Death Data, our study shows that there is a J-/U-shaped relationship between maternal age and adverse fetal and infant outcomes, i.e., the younger (< 20 years) and older ages (> 35 years) are associated with higher risks of adverse outcomes. Our findings suggest that the maternal age for the optimal infant outcomes is around 24 to 31 years old for non-obese first-time mothers in general. Non-Hispanic Black women had the lowest mortality/morbidity rates 2–4 years younger than other race/ethnic groups.
The association between maternal age and adverse infant outcomes results from a mixture of physiological and socioeconomic factors. Physiologically, after puberty, women reach sexually maturity and are prepared to undergo pregnancy. However, young women who are undergoing growth may compete with the developing fetus for intrauterine resources (e.g. nutrients), contributing to restricted fetal growth and, subsequently, place the fetus at the risk for certain health problems.16 Biological immaturity may also predispose young mothers to infection-mediated preterm delivery.17
The risk of adverse pregnancy outcomes gradually rises as the reproductive system mature; increased myometrial sclerotic lesions with advancing age may cause uteroplacental under-perfusion and, consequently, increase the risk of stillbirth.18 Furthermore, chronic diseases (e.g. hypertension, diabetes, renal disease) associated with advancing maternal age, potentially increase the risk of adverse outcomes.19
Heffner et al. suggested that maternal age between 25 and 35 would be ideal for childbearing in westernized societies.20 One retrospective cohort study with 203,517 mothers of singleton gestation found that maternal age of 25–30 years old was associated with the lowest risks of low birth weight (< 2500 g), admission to neonatal intensive care unit and perinatal mortality, after controlling for race, parity, insurance type, BMI, pre-existing medical conditions, substance use, and clinical site.21 Another study using hospital inpatient stay data with 4,109,297 weighted sample, also found that maternal age of 25–29 was related to the lowest odds for most of maternal complications (e.g. chorioamnionitis, preeclampsia, eclampsia, pregnancy-related hypertension) with the adjustment of demographics and comorbidities (e.g. gestational diabetes, cardiac disease).13 However, as adjustment of age-related medical conditions may undermine the total effects of maternal age on pregnancy outcomes, we did not adjust for medical conditions.
Our study is population-based, involving the whole U.S. birth population and examined race/ethnicity-specific patterns. Overall, maternal age associated with the optimal fetal and infant outcomes was 24–31 years old for the vast majority of non-obese first-time women. The optimal age for African American mothers was 2–4 years earlier than other race/ethnic groups. One possible explanation is the cumulative exposure to socioeconomic disadvantage that leads to Black women to experience earlier health deterioration, what Geronimus proposed as “whethering hypothesis”.22 In addition, adaptation to such chronic stress results in wear and tear on the body, which is referred as “allostatic load”.23 Lu and Halfon suggested that allostatic load may affect reproductive health in Black women, which partly explains the racial/ethinic disparities in birth outcomes.24
The current study has several strengths. It included a population-based large sample size, which allowed the analysis of rare outcomes such as fetaland infant mortality. Statistically, we applied a flexible method to fit the non-linear and asymmetric relationship between maternal age and each pregnancy outcome, letting the data determine the functional form of the equation relating maternal age and outcome. Use of the fractional polynomial regression preserves the continuous nature of maternal age and the non-linear nature of the association between maternal age and adverse outcomes, enabling us to find an optimal age rather than an age group.
Nonetheless, our study has some limitations. First, we did not identify the optimal maternal age for maternal morbidity (e.g. hemorrhage, postpartum sepsis, pre-eclampsia/eclampsia), maternal mortality and severe neonatal morbidity because previous studies found that maternal and neonatal morbidity information had substantial underreporting in the birth certificate data.25 We, therefore, used severe small-for-gestational-age and early preterm birth as a combined morbidity index. While severe neonatal outcomes have more clinical implications, less severe morbidity may also have long-term concerns for adult chronic diseases. Second, we could not provide a single index to identify the optimal maternal age, as the incidences of mortality (in per 1,000 births) and morbidity (in per 100 births) differed greatly and the datasets used for fetal and infant mortalities were different; instead, we used three indexes. As the maternal age patterns for mortalities and morbidity were very similar, the conclusion is reassured. Third, the findings in the study apply to non-obese women only. Finally, as we did not have good information on socioeconomic status, the study may be susceptible to residual confounding.